MariMed Announces Management Change and Third Quarter 2023 Earnings Date

Rhea-AI Summary

MariMed Inc. announced the resignation of Susan M. Villare as Chief Financial Officer and the appointment of Jon Levine as Interim CFO. The company will report its Q3 2023 financial results on November 8, 2023, and a conference call will be held on November 9, 2023, to discuss the results.

NORWOOD, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”), (CSE: MRMD), (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced that effective October 31, 2023, Susan M. Villare resigned as Chief Financial Officer of the Company. The Board of Directors has appointed Jon Levine, President and CEO, as the Company’s Interim Chief Financial Officer and has initiated a search process to identify and engage a new Chief Financial Officer.

Additionally, the Company announced it will report third quarter 2023 financial results on November 8, 2023 after the markets close. Management will host a conference call on November 9, 2023 at 8:00 a.m. EST to discuss financial results.

A webcast will be available and can be accessed via MariMed’s Investor Relations website at MariMed Q323 Earnings Webcast. A playback of the call will also be made available on MariMed’s Investor Relations website.

About MariMed
MariMed Inc., a multi-state cannabis operator, is dedicated to improving lives every day through its high-quality products, its actions, and its values. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units. Proprietary formulations created by the Company’s technicians are embedded in its top-selling and award-winning products and brands, including Betty's Eddies, Nature’s Heritage, InHouse, Bubby’s Baked, K Fusion, Kalm Fusion, and Vibations: High + Energy, which are trademarks of MariMed Inc. For additional information, visit https://marimedinc.com.

Investor Relations Contact:
Steve West
Vice President, Investor Relations
Email: ir@marimedinc.com
Phone: (781) 277-0007

Company Contact:
Howard Schacter
Chief Communications Officer
Email: hschacter@marimedinc.com
Phone: (781) 277-0007

FAQ

Who resigned as Chief Financial Officer of MariMed Inc.?

Susan M. Villare resigned as Chief Financial Officer of MariMed Inc.

Who has been appointed as the Interim Chief Financial Officer?

Jon Levine, President and CEO, has been appointed as the Company's Interim Chief Financial Officer.

When will MariMed Inc. report its Q3 2023 financial results?

MariMed Inc. will report its Q3 2023 financial results on November 8, 2023.

When will the conference call to discuss the financial results be held?

The conference call to discuss the financial results will be held on November 9, 2023, at 8:00 a.m. EST.

Where can the webcast of the conference call be accessed?

The webcast of the conference call can be accessed via MariMed's Investor Relations website at MariMed Q323 Earnings Webcast.

Will a playback of the call be available?

Yes, a playback of the call will be made available on MariMed's Investor Relations website.